
Information from the Women's Health Initiative zzso trial has given physicians valuable tools for counseling women aged 50 to 79 years about the short-term risks of hormone therapy zzso zzso questions remain, particularly on the risks and benefits of zzso zzso among long-term zzso The decision to zzso zzso should be carefully considered, because stopping and zzso after several months may zzso the zzso for risks associated with changes in zzso protein zzso The current authors recommend zzso zzso hormonal zzso no large-scale zzso trials exist to confirm the veracity of this zzso It has been suggested that starting zzso in the zzso transition would alleviate the zzso risks observed zzso Until additional data are available to counsel women in the zzso transition, however, the conservative counseling approach is to apply those figures available from the zzso particularly because women aged 50 to 59 years using zzso therapy have an zzso zzso ratio, similar to that seen in older zzso 

